• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过自动化多目标 delta 放射组学模型预测转移性黑色素瘤的免疫治疗疗效。

Immunotherapy treatment outcome prediction in metastatic melanoma through an automated multi-objective delta-radiomics model.

机构信息

School of Information and Communication Engineering, Xi'an Jiaotong University, Xi'an, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.

出版信息

Comput Biol Med. 2021 Nov;138:104916. doi: 10.1016/j.compbiomed.2021.104916. Epub 2021 Oct 9.

DOI:10.1016/j.compbiomed.2021.104916
PMID:34656867
Abstract

Based on recent studies, immunotherapy led by immune checkpoint inhibitors has significantly improved the patient survival rate and effectively reduced the recurrence risk. However, immunotherapy has different therapeutic effects for different patients, leading to difficulties in predicting the treatment response. Conversely, delta-radiomic features, which measure the difference between pre- and post-treatment through quantitative image features, have proven to be promising descriptors for treatment outcome prediction. Consequently, we developed an effective model termed as the automated multi-objective delta-radiomics (Auto-MODR) model for the prediction of immunotherapy response in metastatic melanoma. In Auto-MODR, delta-radiomic features and traditional radiomic features were used as inputs. Furthermore, a novel automated multi-objective model was developed to obtain more reliable and balanced results between sensitivity and specificity. We conducted extensive comparisons with existing studies on treatment outcome prediction. Our method achieved an area under the curve (AUC) of 0.86 in a cross-validation study and an AUC of 0.73 in an independent study. Compared with the model using conventional radiomic features (pre- and post-treatment) only, better performance can be obtained when conventional radiomic and delta-radiomic features are combined. Furthermore, Auto-MODR outperformed the currently available radiomic strategies.

摘要

基于最近的研究,免疫检查点抑制剂主导的免疫疗法显著提高了患者的生存率,并有效地降低了复发风险。然而,免疫疗法对不同的患者有不同的治疗效果,导致治疗反应的预测存在困难。相反,通过定量图像特征测量治疗前后差异的 delta 放射组学特征已被证明是治疗效果预测的有前途的描述符。因此,我们开发了一种名为自动多目标 delta 放射组学(Auto-MODR)的有效模型,用于预测转移性黑色素瘤的免疫治疗反应。在 Auto-MODR 中,delta 放射组学特征和传统放射组学特征被用作输入。此外,还开发了一种新颖的自动化多目标模型,以在敏感性和特异性之间获得更可靠和平衡的结果。我们与现有的治疗效果预测研究进行了广泛的比较。我们的方法在交叉验证研究中获得了 0.86 的曲线下面积(AUC),在独立研究中获得了 0.73 的 AUC。与仅使用传统放射组学特征(治疗前后)的模型相比,当结合使用传统放射组学和 delta 放射组学特征时,可以获得更好的性能。此外,Auto-MODR 优于目前可用的放射组学策略。

相似文献

1
Immunotherapy treatment outcome prediction in metastatic melanoma through an automated multi-objective delta-radiomics model.通过自动化多目标 delta 放射组学模型预测转移性黑色素瘤的免疫治疗疗效。
Comput Biol Med. 2021 Nov;138:104916. doi: 10.1016/j.compbiomed.2021.104916. Epub 2021 Oct 9.
2
Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer.基于 MRI 的预处理、后处理和差值放射组学特征及机器学习算法在结直肠癌中的治疗反应预测。
Med Phys. 2021 Jul;48(7):3691-3701. doi: 10.1002/mp.14896. Epub 2021 May 17.
3
Systematic review of radiomic biomarkers for predicting immune checkpoint inhibitor treatment outcomes.基于影像组学生物标志物预测免疫检查点抑制剂治疗效果的系统综述。
Methods. 2021 Apr;188:61-72. doi: 10.1016/j.ymeth.2020.11.005. Epub 2020 Dec 1.
4
Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.基于机器学习的放射组学模型预测前列腺癌调强放疗反应、Gleason 评分和分期。
Radiol Med. 2019 Jun;124(6):555-567. doi: 10.1007/s11547-018-0966-4. Epub 2019 Jan 3.
5
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.基于影像组学、肿瘤体积和血液生物标志物的免疫检查点抑制剂治疗转移性黑色素瘤患者假性进展的早期预测。
Clin Cancer Res. 2020 Aug 15;26(16):4414-4425. doi: 10.1158/1078-0432.CCR-20-0020. Epub 2020 Apr 6.
6
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.一种基于放射组学的方法来评估肿瘤浸润 CD8 细胞与抗 PD-1 或抗 PD-L1 免疫治疗反应的关系:一项影像学生物标志物、回顾性多队列研究。
Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.
7
Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?Delta放射组学能否改善接受免疫检查点抑制剂治疗的黑色素瘤患者的最佳总体缓解率、无进展生存期和总生存期的预测?
Cancers (Basel). 2024 Jul 26;16(15):2669. doi: 10.3390/cancers16152669.
8
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.磁共振成像放射组学预测术前腋窝淋巴结转移以支持手术决策,并与浸润性乳腺癌的肿瘤微环境相关:一项机器学习、多中心研究。
EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4.
9
An investigation of machine learning methods in delta-radiomics feature analysis.机器学习方法在 delta 放射组学特征分析中的研究。
PLoS One. 2019 Dec 13;14(12):e0226348. doi: 10.1371/journal.pone.0226348. eCollection 2019.
10
Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy.基于影像组学的立体定向体部放疗后胰腺癌预后预测
Cancers (Basel). 2020 Apr 24;12(4):1051. doi: 10.3390/cancers12041051.

引用本文的文献

1
CT delta-radiomics predicts the risks of blood transfusion and massive bleeding during spinal tumor surgery.CT 影像组学预测脊柱肿瘤手术期间输血和大量出血的风险。
Cancer Imaging. 2025 Jun 22;25(1):79. doi: 10.1186/s40644-025-00900-1.
2
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.转移性黑色素瘤患者对免疫疗法和BRAF靶向疗法反应的患者及器官间异质性的放射组学分析。
J Immunother Cancer. 2025 Feb 12;13(2):e009568. doi: 10.1136/jitc-2024-009568.
3
Machine learning in the prediction of immunotherapy response and prognosis of melanoma: a systematic review and meta-analysis.
机器学习在预测黑色素瘤免疫治疗反应和预后中的应用:系统评价和荟萃分析。
Front Immunol. 2024 May 21;15:1281940. doi: 10.3389/fimmu.2024.1281940. eCollection 2024.
4
Delta-radiomics in cancer immunotherapy response prediction: A systematic review.癌症免疫治疗反应预测中的德尔塔放射组学:一项系统综述。
Eur J Radiol Open. 2023 Jul 18;11:100511. doi: 10.1016/j.ejro.2023.100511. eCollection 2023 Dec.
5
Towards reliable head and neck cancers locoregional recurrence prediction using delta-radiomics and learning with rejection option.利用δ放射组学和带有拒绝选项的学习进行可靠的头颈部癌症局部区域复发预测。
Med Phys. 2023 Apr;50(4):2212-2223. doi: 10.1002/mp.16132. Epub 2022 Dec 17.
6
Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics.基于动态对比增强磁共振成像(DCE-MRI)影像组学特征的无监督分析揭示了三种具有不同临床结局和生物学特征的新型乳腺癌亚型。
Cancers (Basel). 2022 Nov 9;14(22):5507. doi: 10.3390/cancers14225507.
7
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy.利用抗 PD-1 免疫治疗的晚期黑色素瘤患者中 CD8 细胞的验证特征,通过放射组学评估病变间异质性并预测病变反应和患者结局。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-004867.
8
Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?成像方法和放射组学:迈向超精准放射免疫治疗的新时代?
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004848.